StonvexLoading…
StonvexStonvexStonvexCore line items from AMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $935.90M | $774.60M | $747.30M | $840.70M |
Operating Income | $4.85B | $4.52B | $3.13B | $2.74B |
Net Income | $2.63B | $2.28B | $1.37B | $1.70B |
EPS (Diluted) | $5.40 | $4.82 | $3.18 | $3.82 |
Total Assets | $63.19B | $61.08B | $66.03B | $67.19B |
Total Liabilities | $52.84B | $51.43B | $55.16B | $54.79B |
Cash & Equivalents | $1.47B | $2.00B | $1.75B | $1.55B |
Free Cash Flow OCF − CapEx | $3.78B | $3.70B | $2.92B | $1.82B |
Shares Outstanding | 466.32M | 467.38M | 466.30M | 465.62M |